Current practice in the management of paediatric autoimmune liver disease in Europe
Treatment of pAILD in Europe varies widely in terms of medications used and treatment monitoring. Availability of paediatric drug formulations across Europe is limited. Collaborative initiatives are needed to define evidence-based strategies for management of pAILD and to promote an equal, age-appropriate treatment for affected children.
Authors
- Gustav Buescher (ORCID: https://orcid.org/0000-0002-3865-5235)
- Marianne Samyn (ORCID: https://orcid.org/0000-0003-3837-2304)
- Ruth De Bruyne (ORCID: https://orcid.org/0000-0002-5623-3300)
- Marianne Hørby Jørgensen (ORCID: https://orcid.org/0000-0003-0658-4636)
- Mara Cananzi (ORCID: https://orcid.org/0000-0002-7177-2847)
Institutions
- University of Padua (IT)
- Universität Hamburg (DE)
- Ghent University Hospital (BE)
- Rigshospitalet (DK)
- University Medical Center Hamburg-Eppendorf (DE)
- King's College Hospital (GB)
Publication Details
- Journal
- Journal of Pediatric Gastroenterology and Nutrition
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1002/jpn3.12424
- Citations
- 5
- Primary Topic
- Liver Diseases and Immunity
- Type
- article
- Field-Weighted Citation Impact
- 1.85
Funders
- University of Pittsburgh
- Hôpitaux Universitaires de Genève